Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017 Apr 28;17(1):116.
doi: 10.1186/s12887-017-0868-y.

Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents

Affiliations
Clinical Trial

Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents

Tenna Ruest Haarmark Nielsen et al. BMC Pediatr. .

Abstract

Background: Dyslipidemia is reported in 27 - 43% of children and adolescents with overweight/obesity and tracks into adulthood, increasing the risk of cardiovascular morbidity. Cut-off values for fasting plasma lipid concentrations are typically set at fixed levels throughout childhood. The objective of this cross-sectional study was to generate fasting plasma lipid references for a Danish/North-European White population-based cohort of children and adolescents, and investigate the prevalence of dyslipidemia in this cohort as well as in a cohort with overweight/obesity.

Methods: A population-based cohort of 2141 (1275 girls) children and adolescents aged 6 - 19 (median 11.5) years was recruited from 11 municipalities in Denmark. Additionally, a cohort of children and adolescents of 1421 (774 girls) with overweight/obesity aged 6 - 19 years (median 11.8) was recruited for the study. Height, weight, and fasting plasma lipid concentrations were measured on all participants. Smoothed reference curves and percentiles were generated using the Generalized Additive Models for Location Scale and Shape package in the statistical software R.

Results: In the population-based cohort, plasma concentrations of total cholesterol (TC) (P < 0.05), low-density lipoprotein cholesterol (LDL) (P < 0.005), and high-density lipoprotein cholesterol (HDL) (P < 0.005) were higher in the youngest compared to the oldest tertile. Fasting plasma levels of triglycerides (TG) (P < 0.005) increased with age in both sexes. In boys, non-HDL was lower in the oldest compared to the youngest tertile (P < 0.0005). Concentrations of TC, LDL, non-HDL, and TG were higher (P < 0.05), and HDL lower (P < 0.05) in the cohort with overweight/obesity in both sexes and for all ages except for TC in the youngest girls. The overall prevalence of dyslipidemia was 6.4% in the population-based cohort and 28.0% in the cohort with overweight/obesity. The odds ratio for exhibiting dyslipidemia in the cohort with overweight/obesity compared with the population-based cohort was 6.2 (95% CI: 4.9 - 8.1, P < 2*10-16).

Conclusion: Fasting plasma lipid concentrations change during childhood and adolescence and differ with sex and age. Children and adolescents with obesity have increased concentrations of circulating lipids and exhibit an increased prevalence of dyslipidemia.

Trial registration: The study is part of The Danish Childhood Obesity Biobank; ClinicalTrials.gov ID-no.: NCT00928473 retrospectively registered on June 25th 2009.

Keywords: Adolescent; Child; Dyslipidemias; Lipids; Obesity; Reference values.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Age distribution. Number of children and adolescents within each age group in the population-based cohort generating the fasting plasma lipid reference intervals. a Girls. b Boys
Fig. 2
Fig. 2
Percentile curves for concentrations of fasting plasma total cholesterol. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile curves for TC in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s Obesity Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of TC are in mmol/L
Fig. 3
Fig. 3
Percentile curves for concentrations of fasting plasma low-density lipoprotein. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile curves for LDL in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s Obesity Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of LDL are in mmol/L
Fig. 4
Fig. 4
Percentile curves for concentrations of fasting plasma high-density lipoprotein. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile curves for HDL in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s Obesity Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of HDL are in mmol/L
Fig. 5
Fig. 5
Percentile curves for concentrations of fasting plasma non-high-density lipoprotein. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile curves for non-HDL in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s Obesity Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of non-HDL are in mmol/L
Fig. 6
Fig. 6
Percentile curves for concentrations of fasting plasma triglycerides. Smoothed 2.5th, 5th, 50th, 90th, 95th and 97.5th percentile curves for TG in girls (a) and boys (b). Full lines represent the total reference population, and dotted lines represent the cohort from The Children’s Obesity Clinic with overweight/obesity. The dots represent the participants from the population-based cohort. Concentrations of TG are in mmol/L

References

    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2095–2128. doi: 10.1016/S0140-6736(12)61728-0. - DOI - PMC - PubMed
    1. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur Heart J. 2012;33(13):1635–1701. doi: 10.1093/eurheartj/ehs092. - DOI - PubMed
    1. Kavey R-EW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107(11):1562–1566. doi: 10.1161/01.CIR.0000061521.15730.6E. - DOI - PubMed
    1. Nomikos T, Panagiotakos D, Georgousopoulou E, Metaxa V, Chrysohoou C, Skoumas I, et al. Hierarchical modelling of blood lipids’ profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study. Lipids Health Dis. 2015;14:108. doi: 10.1186/s12944-015-0101-7. - DOI - PMC - PubMed
    1. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children And Adolescents Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics. 2011;128(Supplement 5):S213–S256. doi: 10.1542/peds.2009-2107C. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data